Home Cart Sign in  
Chemical Structure| 2230186-18-0 Chemical Structure| 2230186-18-0

Structure of VB124
CAS No.: 2230186-18-0

Chemical Structure| 2230186-18-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

VB124 is a selective MCT4 inhibitor primarily used in research on cardiac hypertrophy and metabolism.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of VB124

CAS No. :2230186-18-0
Formula : C23H23ClN2O4
M.W : 426.89
SMILES Code : CC(C)(OCC1=NN(C2=CC=CC=C2Cl)C(C3=CC=CC(OC4CC4)=C3)=C1)C(O)=O
MDL No. :MFCD34602725

Safety of VB124

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
H9c2 cells 10 μM 24 h Induced cellular hypertrophy PMC7933116
H9c2 cells 20 μM 48 h Prevented and reversed cellular hypertrophy PMC7933116
Primary cultured adult mouse cardiomyocytes (ACM) 20 μM 24 h Mitigated cellular hypertrophy PMC7933116

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Cardiac hypertrophy model Oral 30 mg/kg Twice per day for 28 days Prevented cardiac hypertrophy PMC7933116
Mice Myocardial ischemia-reperfusion injury model Oral gavage 30 mg/kg Single dose, lasting 3 weeks VB124 treatment increased myocardial salvage and improved cardiac function. PMC11385101

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.34mL

0.47mL

0.23mL

11.71mL

2.34mL

1.17mL

23.43mL

4.69mL

2.34mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories